(Q54403595)

English

Correlation between tuberous sclerosis complex 2 and glycogen synthase kinase 3 beta levels, and outcomes of patients with hepatocellular carcinoma treated by hepatectomy.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24119083

Correlation between tuberous sclerosis complex 2 and glycogen synthase kinase 3 beta levels, and outcomes of patients with hepatocellular carcinoma treated by hepatectomy. (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24119083

1 reference

based on heuristic

inferred from title

tuberous sclerosis

1 reference

based on heuristic

inferred from title

tuberous sclerosis 1

1 reference

based on heuristic

inferred from title

author name string

Ka-Te Huang

1

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24119083

Yue-Han Huang

2

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24119083

Peng Li

3

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24119083

Bin He

4

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24119083

Zhen-Kun Chen

5

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24119083

Xia Yu

6

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24119083

Jian-Ou Chen

7

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24119083

Qi-Yu Zhang

8

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24119083

Hong-Qi Shi

9

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24119083

Yun-Feng Shan

10

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24119083

publication date

8 November 2013

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24119083

Hepatology Research

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24119083

44

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24119083

11

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24119083

1142-1150

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24119083

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12256

21 January 2018

SIRT1 promotes tumorigenesis and resistance to chemotherapy in hepatocellular carcinoma and its expression predicts poor prognosis

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12256

21 January 2018

Oncogene-specific activation of tyrosine kinase networks during prostate cancer progression

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12256

21 January 2018

Rapid, Wnt-induced changes in GSK3beta associations that regulate beta-catenin stabilization are mediated by Galpha proteins

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12256

21 January 2018

Glycogen synthase kinase 3beta (GSK3beta) in tumorigenesis and cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12256

21 January 2018

Deregulated GSK3{beta} sustains gastrointestinal cancer cells survival by modulating human telomerase reverse transcriptase and telomerase.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12256

21 January 2018

TSC2 mediates cellular energy response to control cell growth and survival

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12256

21 January 2018

Tuberin and hamartin are aberrantly expressed and linked to clinical outcome in human breast cancer: the role of promoter methylation of TSC genes

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12256

21 January 2018

Involvement of TSC genes and differential expression of other members of the mTOR signaling pathway in oral squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12256

21 January 2018

TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12256

21 January 2018

Reduced expression of Krüppel-like factor 17 is related to tumor growth and poor prognosis in lung adenocarcinoma

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12256

21 January 2018

Acute WNT signalling activation perturbs differentiation within the adult stomach and rapidly leads to tumour formation

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12256

21 January 2018

Aberrant Wnt1/β-catenin expression is an independent poor prognostic marker of non-small cell lung cancer after surgery.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12256

21 January 2018

Prognostic value of interleukin 2 and interleukin 15 in peritumoral hepatic tissues for patients with hepatitis B-related hepatocellular carcinoma after curative resection

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12256

21 January 2018

Expression, cellular distribution, and prognostic relevance of TRAIL receptors in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12256

21 January 2018

Acetylcholinesterase, a key prognostic predictor for hepatocellular carcinoma, suppresses cell growth and induces chemosensitization

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12256

21 January 2018

Glycogen synthase kinase 3 beta mediates high glucose-induced ubiquitination and proteasome degradation of insulin receptor substrate 1.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12256

21 January 2018

Expression of cyclooxygenase-2 is regulated by glycogen synthase kinase-3beta in gastric cancer cells

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12256

21 January 2018

GSK3β and cyclin D1 expression predicts outcome in early breast cancer patients.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12256

21 January 2018

Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12256

21 January 2018

Antroquinonol displays anticancer potential against human hepatocellular carcinoma cells: a crucial role of AMPK and mTOR pathways.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12256

21 January 2018

The mTOR pathway and its role in human genetic diseases

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12256

21 January 2018

Positive and negative regulation of TSC2 activity and its effects on downstream effectors of the mTOR pathway

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12256

21 January 2018

Inhibition of mTOR enhances chemosensitivity in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12256

21 January 2018

mTOR inhibitor for the treatment of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12256

21 January 2018

mTOR and P70 S6 kinase expression in primary liver neoplasms

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12256

21 January 2018

Pivotal role of mTOR signaling in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12256

21 January 2018

Tuberous sclerosis complex-associated angiomyolipomas: focus on mTOR inhibition.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12256

21 January 2018

Evidence for population variation in TSC1 and TSC2 gene expression

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12256

21 January 2018

The long and winding road to rational treatment of cancer associated with LKB1/AMPK/TSC/mTORC1 signaling

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12256

21 January 2018

The tuberous sclerosis complex: balancing proliferation and survival

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12256

21 January 2018

Mechanism of Akt1 inhibition of breast cancer cell invasion reveals a protumorigenic role for TSC2.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12256

21 January 2018

The LKB1-AMPK pathway: metabolism and growth control in tumour suppression

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12256

21 January 2018

Identifiers

10.1111/HEPR.12256

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24119083

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24119083

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54403595&oldid=1586323069"